Evidence map›Paper›PMID 35870076›Full record

Trial reportPhotochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology2022

Innovative digital solution supporting sun protection and vitamin D synthesis by using satellite-based monitoring of solar radiation.

Antony R Young, Sérgio Schalka, Rowan C Temple, Emilio Simeone, Myriam Sohn, Christina Kohlmann, Marco Morelli

Open access · bronzeAbstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Antony R YoungSt John's Institute of Dermatology, King's College London, London, UK.ORCID http://orcid.org/0000-0002-4163-6772
Sérgio SchalkaDepartment of Dermatology, Medcin Clinical Research Center, Osasco, SP, Brazil.ORCID http://orcid.org/0000-0003-2425-7962
Rowan C TemplesiHealth Ltd, Harwell Campus, Didcot, Oxfordshire, UK.ORCID http://orcid.org/0000-0002-2461-9022
Emilio SimeonesiHealth Ltd, Harwell Campus, Didcot, Oxfordshire, UK.ORCID http://orcid.org/0000-0001-9633-618X
Myriam SohnBASF Grenzach GmbH, Grenzach-Wyhlen, Germany.ORCID http://orcid.org/0000-0002-1322-7648
Christina KohlmannBASF Personal Care and Nutrition GmbH, Düsseldorf, Germany.
Marco MorellisiHealth Ltd, Harwell Campus, Didcot, Oxfordshire, UK. marco.morelli@sihealth.co.uk.ORCID http://orcid.org/0000-0002-4118-3849
iHealth · GBKing's College London · GBMedcin Dermatologia · BRResearch Complex at Harwell · GB

Funding

European Space Agency 4000120541/17/NL/US
6 · The paper itself

Abstract

Public health campaigns advise minimising UV radiation (UVR) exposure to prevent skin cancer and precancer, e.g. actinic keratosis (AK). A 3-day clinical field study, in Brazil, was performed to evaluate the mobile app Sun4Health® by siHealth Ltd. The app performs real-time monitoring of both erythemal and vitamin D-effective solar radiation doses using satellite data, enabling personalised recommendations on optimal sun exposure time and sunscreen use. When coupled to a wearable device, the app also provides body-site specific recommendations ("3D" version). 59 healthy volunteers were randomised into 3 groups, each given a different app providing: (1) ultraviolet index only (control app), (2) personalised recommendations and sun overexposure alerts (Sun4Health® app), (3) as (2) but connected via Bluetooth to a wearable device to monitor sun exposure in 3D (Sun4Health®-3D app). Participants were offered sunscreens (SPF 30 and 50) to use at their discretion. Erythema, quantified by reflectance spectroscopy, was assessed daily in the mornings and evenings on six body sites. Serum vitamin D (25(OH)D

Indexed as

SunburnUltraviolet RaysErythemaHumansSunscreening AgentsVitamin DSunscreening AgentsVitamin DActinic keratosisAppClinical field studyErythemaPersonalised recommendationsSkin cancerSun protectionVitamin DWearable

Identifiers

PMID35870076
OpenAlexW4286750389

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.